Navigation Links
GeneChoice TEMPase II DNA Polymerase from GeneChoice, Inc.

ProductsGeneChoice TEMPase II DNA Polymerase from GeneChoice, Inc.
Company GeneChoice, Inc.
Item GeneChoice TEMPase II DNA Polymerase
Price $220.00
Description • Heat activated
• Eliminates nonspecific products due to inactivity at room temperature
• Excellent specificity allows extension through DNA regions which contain repeats and secondary structures
• Leaves an 'A' overhang

TEMPase II is a chemically modified form of GeneChoice DNA Polymerase that remains inactive at room temperature and works optimally in a distinctive buffer system.

TEMPase II is useful for performing automated hot start amplification due to its thermal activation at a temperature well above optimal annealing. The enzyme remains inactive until the time, temperature, and pH are optimal. During hot start, primers bind only to their specific target, and polymerase activity is directed exclusively to that target. As a result, only the region of interest is amplified, which increases sensitivity and yield while reducing non-specific background amplification.

Once the reaction reaches optimal annealing temperatures after a 15 minute activation step at 95C, the enzyme stays activated in the reaction.

Since the enzyme is chemically modified for hot start (no antibody), there is no material from animal sources, i.e., there is no possibility for biological contamination.

10X TEMPase II Reaction Buffer - Combination of (NH4)2S04 and KCl, 15 mM MgCl2, 1% Tween 20.
25 mM MgCl2 Solution - Supplied.
Info GeneChoice, Inc.GeneChoice, Inc.
7307 Governors Way
Frederick, MD 21703 USA

Call GeneChoice, Inc. to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-772-8354
Customer Service: 866-636-2200
Fax Number: 301-620-0162
Web Site: http://www.genechoiceinc.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. GeneChoice Taq DNA Polymerase With Standard Buffer from GeneChoice, Inc.
2. GeneChoice Taq DNA Polymerase With Ammonium Buffer from GeneChoice, Inc.
3. GeneChoice Taq DNA Polymerase With Magnesium Free Standard Buffer from GeneChoice, Inc.
4. GeneChoice RNA Safe Recombinant Ribonuclease Inhibitor from GeneChoice, Inc.
5. T4 DNA Polymerase from Roche Applied Science
6. T4 DNA Polymerase from Roche Applied Science
7. Poly A Polymerase from Invitrogen
8. iTaq DNA Polymerase, 250 U from Bio-Rad
9. iTaq DNA Polymerase, 5,000 U from Bio-Rad
10. Taq DNA Polymerase, 500 U (2 x 250 U) without dNTP from Bioneer, Inc.
11. T4 DNA Polymerase from Invitrogen
Anti-Monocarboxylate Transporter 2 (MCT2) Polyclonal Antibody, Unconjugated from CHEMICON
Mouse Anti-Human Relaxin-2, pro- Monoclonal Antibody, Unconjugated, Clone fred from Immundiagnostik
Rabbit Anti-Chicken IgY, IgG F(ab')2 fragment Antibody, Biotin Conjugated from Biomeda Corporation
Anti-Chloride Channel, CLC-2 Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products:
(Date:11/23/2009)...gton, CT Current research suggests that a common ... The related report by Nichols et al, "Unique Lipi...lass of TLR2 Ligands Capable of Enhancing Autoimmu...American Journal of Pathology . , Multiple scler...ks the brain and spinal cord, affects nearly 1 in ...
(Date:11/23/2009)..., Iowa - The only swine vaccine available for the ... infected with the virus. The vaccination marks th... diagnosed with the pandemic flu., Iowa State Un...e, developed the vaccine this summer and has been ...wa, Kansas and Illinois for several weeks., The ...
(Date:11/23/2009)...N, WI, November 16, 2009 -- A USDOE and USDA study... idle cropland, and cropland pasture could be conv...nial grasses, such as switchgrass, from which biom...ock. Economically viable production of a perennial...es of biomass are removed annually is expected to ...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Switchgrass produces biomass efficiently 2Labopharm amends debt facility agreement with Hercules 50014 1Labopharm amends debt facility agreement with Hercules 50014 2Labopharm amends debt facility agreement with Hercules 50014 3Richard A Meier Appointed to STAAR Surgical Board of Directors 50011 1Richard A Meier Appointed to STAAR Surgical Board of Directors 50011 2Richard A Meier Appointed to STAAR Surgical Board of Directors 50011 3Richard A Meier Appointed to STAAR Surgical Board of Directors 50011 4OptoElectronix Offers Lighting Manufacturers A Unique Integrated LED Light Engine With 1 000 Lumens Light Output 50007 1OptoElectronix Offers Lighting Manufacturers A Unique Integrated LED Light Engine With 1 000 Lumens Light Output 50007 2OptoElectronix Offers Lighting Manufacturers A Unique Integrated LED Light Engine With 1 000 Lumens Light Output 50007 3
...To help improve the success of oyster restoration ...and Center for Environmental Science researcher Dr...in a new in-depth study to determine when oysters ...ver. Her team,s research is supported by a $750,00...dation. , Working with fellow UMCES Horn Point La...
...f women with breast cancer today are candidates fo... their breast tissue. Results of a UC Davis study,... recurs in the same breast are treated with a seco...rrent treatment recommendations and cutting the nu... were surprised to find that so many women in our ...
..., the oil industry will need more refined tools fo...before taken place, geologists say. , One such to...ment-on-the-move is deposited), derived from sedim... ago, scientists report in this week,s issue of th... entire Paleozoic Era. , "The new Paleozoic sea-l...
Other Biology News:Second lumpectomy for breast cancer reduces survival rates 2Paleozoic 'sediment curve' provides new tool for tracking sea-floor sediment movements 2
(Date:11/25/2009)... , BEIJING, Nov. 25 /PRNewswire-A...eloper and provider of vaccines, announced today t...establish Sinovac (Dalian) Vaccine,Technology Co.,...lop, produce,and commercialize human-use vaccines....nce in developing and commercializing world-class ...
(Date:11/24/2009)... Ambassador to also Visit De...24, 2009 -- , , ,Who: David Appia, French Ambassad...CEO of the Invest in France Agency, , , , ,What: ...o discuss recent pro-business initiatives adopted ... and academic landscape for innovation and develop...
(Date:11/24/2009)... , ST. LOUIS, Nov. 24 /PRNewswire-FirstCa...will be presenting at the NASDAQ OMX conference on...:45 AM US/CST. Interested parties may listen via l... http://inve s tor.sig m a a ldrich.com/ ...is file. ,, About Sigma-Aldrich: Sigma-Al...
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-As...e Food & Drug Administration (SFDA) has approv...for its oral insulin project,(Nodlin), an innovati...,approval allows Biolaxy to initiate its first pha...rder characteristic of high blood glucose and poor...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Biolaxy Secures IND Approval for Oral Insulin 2